MedtechInsight.com

Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
Home

Online Report Subscribers, Click Here

Pricing and Ordering Information

China Disease Incidence & Prevalence Report
Report #CS300CH - December 2011

China Disease Incidence and Prevalence: A changing disease profile in China has lead to a transition from infectious diseases to chronic diseases, with more than 2.2 million new cases of cancer diagnosed annually, and one in five adults suffering from cardiovascular disease.

China has a population of 1.3 billion people and is now the world’s largest economy after the US. The country’s healthcare and disease profiles are undergoing significant changes spurred by rapid economic, social and demographic developments over the last three decades. With a large population base, a growing middle class and a widespread aging population, China is combating a rapid rise in chronic diseases while still addressing high profile infectious diseases. There is now greater attention paid to the growing incidence of chronic diseases that can cause a significant economic burden, e.g., China has more than 2.2 million new cases of cancer diagnosed annually.

The prevalence of cardiovascular disorders illustrates the magnitude of the impending challenge for the Chinese government. It is estimated that there are 230 million patients with cardiovascular disease, of which 200 million are affiliated with hypertension, seven million with stroke, two million with myocardial infarction, six million with heart failure, 2.5 million with rheumatic heart disease and two million with congenital heart disease. In other words one in every five adults in China suffer from cardiovascular disease and an estimated three million Chinese die of cardiovascular disease annually, which is the leading cause of death and accounts for 41% of all deaths in China.

The control of infectious disease prevalence associated with the large rural population is still a focus in China, especially with the increasing disparity in terms of economics, social structure, and healthcare provision between rural and urban China. While the incidences of infectious diseases are decreasing, diseases such as malaria, gonorrhoea and syphilis are common and there are still more than 990,000 new cases of tuberculosis and 250,000 cases of dysentery annually.

These pressures have contributed to the healthcare reform that was announced in 2009, which was initiated to provide accessible and affordable care to all Chinese citizens by 2020. There are five key elements of reform, namely:

Expand the basic medical insurance programs to cover both urban and rural populations;
Establish a national essential drug system to be initially implemented in community health centers and county hospitals;
Strengthen the primary health infrastructure in rural and urban areas;
Improve public health services and guarantee access to those services; and
Reform public hospitals.

Healthcare reform is now being implemented across China, but with varied levels of results due to the availability of funding from local government, as well as differences inthe local implementation of national reform guidelines.

Ordering Information

Title	Report#	Publication Date	List Price
China Disease Incidence & Prevalence Report	CS300CH	December 2011	$5,950
Order Online: Single User only (Please call for corporate subscription pricing)			PDF Only

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

TABLE OF CONTENTS

1. CHINA HEALTHCARE OVERVIEW

1.1 Macroeconomic view

1.2 Social and demographic factors

1.3 Healthcare reform

1.4 Hospital services

1.5 Medical devices

Exhibit 1-1: Key Economic & Health Statistics

Exhibit 1-2: Breakdown of Population Age By Province in China

Exhibit 1-3: Top 10 causes of Death in China

2. BLOOD DISORDERS

2.1 Anemia

2.1.1 Iron Deficiency Anemia

2.1.2 Sickle Cell Anemia

2.1.3 Thalassemia

2.2 Hemophilia

Exhibit 2-1: China, Prevalence of Blood Disorders

3. CANCER

3.1 Bladder cancer

3.2 Brain tumor

3.3 Breast cancer

3.4 Cervical/uterine cancer

3.5 Colon/Rectal Cancer

3.6 Leukemia

3.7 Liver Cancer

3.8 Lung Cancer

3.9 Lymphoma

3.10 Melanoma

3.11 Oesophageal Cancer

3.12 Oral Cancer

3.13 Ovarian Cancer

3.14 Pancreatic Cancer

3.15 Prostrate Cancer

3.16 Stomach Cancer

Exhibit 3-1: China, Incidence of Cancer

4. CARDIOVASCULAR DISORDERS

4.1 Cardiac Arrhythmia

4.2 Dyslipidemia

4.3 Heart Failure

4.4 Heart Valve Disorders

4.5 Hypertension

4.6 Vascular Disorders

4.6.1 Atherosclerosis

4.6.2 Ischemic Heart Disease

4.6.3 Myocardial Infarction

4.6.4 Peripheral Vascular Disease

Exhibit 4-1: China, Prevalence of Cardiovascular Disorders

5. METABOLIC DISORDERS

5.1. Cholelithiasis and cholecystitis

5.2 Chronic Kidney Disease/End-Stage Renal Disease

5.3 Diabetes

5.4 Fatty Liver

5.5 Urolithiasis

5.6 Peptic Ulcer

Exhibit 5-1: China, Prevalence of Cardiovascular Disorders

6. MUSCULOSKELTAL DISORDERS

6.1. Arthritis

6.1.1 Osteoarthritis

6.1.2 Rheumatoid Arthritis

6.2 Carpal Tunnel Syndrome

6.3 Intervertebral Disc Disorder

6.4 Osteoporosis

Exhibit 6-1: China, Prevalence of Musculoskeletal Disorders

7. NEUROLOGIC AND PSYCHIATRIC DISORDERS

7.1 Alzheimer’s disease

7.2 Bipolar disorder

7.3 Cerebrovascular Disease

7.3.1 Cerebral Aneurysm

7.3.2 Stroke

7.4 Depression

7.5 Epilepsy

7.6 Hydrocephalus

7.7 Multiple Sclerosis

7.8 Myasthenia Gravis

7.9 Parkinson’s Disease

7.10 Schizophrenia

Exhibit 7-1: China, Prevalence of Neurologic and Psychiatric Disorders

8. OPHTHALMIC DISORDERS

8.1 Cataracts

8.2 Glaucoma

Exhibit 8-1: China, Prevalence of Neurologic and Psychiatric Disorders

9. REPRODUCTIVE AND GENITOURINARY DISORDERS

9.1 Benign Prostatic Hyperplasia

9.2 Endometriosis

9.3 Erectile Dysfunction

9.4 Infertility

9.5 Urinary Incontinence

Exhibit 9-1: China, Prevalence of Reproductive and Genitourinary Disorders

10. RESPIRATORY DISORDERS

10.1 Asthma

10.2 Bronchiectasis

10.3 Chronic Obstructive Pulmonary Disease

10.4 Pulmonary Embolism

Exhibit 10-1: China, Prevalence of Respiratory Disorders

11. WOUNDS

11.1 Diabetic Ulcer

11.2 Pressure Ulcers

11.3 Surgical Wounds

11.4 Traumatic Wounds

11.4.1 Amputation

11.4.2 Burns

Exhibit 11-1: China, Prevalence of Wounds

12. SELECTED CONDITIONS CAUSED BY INFECTIOUS ORGANISMS

12.1 Brucellosis

12.2 Dysentery

12.3 Gonorrhea

12.4 Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome

12.5 Measles

12.6 Syphilis

12.7 Tuberculosis

12.8 Viral Hepatitis

Exhibit 12-1: China, Incidence of Conditions Caused by Infectious Organisms

Clearstate is a market intelligence firm offering customized strategic advisory and primary research solutions specifically addressing the Healthcare and Life Sciences domains within the Asia Pacific region. www.clearstate.com

To order reports or obtain information about special pre-publication offers from within the U.S., contact reports@elsevier.com. You can also call 1.949.453.0071 (or toll-free within the U.S. at 1.888.290.2225) or fax 1.949.453.0072.